GILD Stock Price and Chart — BCS:GILD — TradingView

Overview

Financials News Ideas Technicals Forecast

GILD chart

Key stats

About GILEAD SCIENCES INC

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

‪0.00‬

Ideas

See all ideas

News

Technicals

Summarizing what the indicators are suggesting.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Stocks, Futures

4.4Very Good

Interactive Brokers

4.4Very Good

See all brokers

Curated watchlists where GILD is featured.

Biotech stocks: A shot in the arm

Cancer research stocks: Oncology pharmaceutical market

See all sparks

Frequently Asked Questions

The current price of GILD is 65.55 USD — it hasn't changed in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on BCS exchange GILEAD SCIENCES INC stocks are traded under the ticker GILD.

GILEAD SCIENCES INC is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.

One year price forecast for GILEAD SCIENCES INC has a max estimate of 121.00 USD and a min estimate of 69.00 USD.

GILD earnings for the last quarter are 2.29 USD whereas the estimation was 1.92 USD which accounts for 19.50% surprise. Estimated earnings for the next quarter are 1.76 USD. See more details about GILEAD SCIENCES INC earnings.

GILEAD SCIENCES INC revenue for the last quarter amounts to ‪7.05 B‬ USD despite the estimated figure of ‪6.81 B‬ USD. In the next quarter revenue is expected to reach ‪7.10 B‬ USD.

Yes, you can track GILEAD SCIENCES INC financials in yearly and quarterly reports right on TradingView.

Like other stocks, GILD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GILEAD SCIENCES INC stock right from TradingView charts — choose your broker and connect to your account.

GILD reached its all-time high on Jun 3, 2015 with the price of 114.26 USD, and its all-time low was 56.95 USD and was reached on Dec 29, 2020.
See other stocks reaching their highest and lowest prices.

As of Apr 18, 2024, the company has ‪18.00 K‬ employees. See our rating of the largest employees — is GILEAD SCIENCES INC on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GILEAD SCIENCES INC EBITDA is ‪11.88 B‬ USD, and current EBITDA margin is 45.96%. See more stats in GILEAD SCIENCES INC financial statements.